0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-depressant Drugs Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-38K7766
Home | Market Reports | Health | Pharmacy | Drugs & Medications
Global Anti depressant Drugs Market Insights and Forecast to 2028

Global Anti-depressant Drugs Market Insights and Forecast to 2028

Code: QYRE-Auto-38K7766
Report
January 2022
112 Pages
QYResearch
Region: United States, Global,
Description
Table of Content
Tables & Figures
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
Market Analysis and Insights: Global Anti-depressant Drugs Market

Due to the COVID-19 pandemic, the global Anti-depressant Drugs market size is estimated to be worth US$ 11910 million in 2022 and is forecast to a readjusted size of US$ 13890 million by 2028 with a CAGR of 2.6% during the review period.

Fully considering the economic change by this health crisis, Selective Serotonin Reuptake Inhibitor (SSRI) accounting for % of the Anti-depressant Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Major Depressive Disorder segment is altered to an % CAGR throughout this forecast period.
Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others)
Global Anti-depressant Drugs Scope and Segment
Anti-depressant Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti-depressant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Selective Serotonin Reuptake Inhibitor (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Tricyclic Antidepressant (TCA)
Monoamine Oxidase Inhibitor (MAOI)
Others

Segment by Application

Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others

BY COMPANY

Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
Teva Pharmaceutical Industries
Takeda Pharmaceutical Company
AstraZeneca
Johnson and Johnson
Sanofi
Sun Pharmaceuticals

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Anti-depressant Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-depressant Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
1.2.4 Tricyclic Antidepressant (TCA)
1.2.5 Monoamine Oxidase Inhibitor (MAOI)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Anti-depressant Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Major Depressive Disorder
1.3.3 Obsessive-Compulsive Disorder
1.3.4 Generalized Anxiety Disorder
1.3.5 Panic Disorder
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-depressant Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-depressant Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-depressant Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-depressant Drugs Sales by Region
2.4.1 Global Anti-depressant Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti-depressant Drugs by Region (2023-2028)
2.5 Global Anti-depressant Drugs Revenue by Region
2.5.1 Global Anti-depressant Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti-depressant Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-depressant Drugs Sales by Manufacturers
3.1.1 Global Top Anti-depressant Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-depressant Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-depressant Drugs in 2021
3.2 Global Anti-depressant Drugs Revenue by Manufacturers
3.2.1 Global Anti-depressant Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-depressant Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-depressant Drugs Revenue in 2021
3.3 Global Anti-depressant Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-depressant Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-depressant Drugs Sales by Type
4.1.1 Global Anti-depressant Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti-depressant Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-depressant Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti-depressant Drugs Revenue by Type
4.2.1 Global Anti-depressant Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-depressant Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti-depressant Drugs Price by Type
4.3.1 Global Anti-depressant Drugs Price by Type (2017-2022)
4.3.2 Global Anti-depressant Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-depressant Drugs Sales by Application
5.1.1 Global Anti-depressant Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anti-depressant Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-depressant Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anti-depressant Drugs Revenue by Application
5.2.1 Global Anti-depressant Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-depressant Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anti-depressant Drugs Price by Application
5.3.1 Global Anti-depressant Drugs Price by Application (2017-2022)
5.3.2 Global Anti-depressant Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-depressant Drugs Market Size by Type
6.1.1 North America Anti-depressant Drugs Sales by Type (2017-2028)
6.1.2 North America Anti-depressant Drugs Revenue by Type (2017-2028)
6.2 North America Anti-depressant Drugs Market Size by Application
6.2.1 North America Anti-depressant Drugs Sales by Application (2017-2028)
6.2.2 North America Anti-depressant Drugs Revenue by Application (2017-2028)
6.3 North America Anti-depressant Drugs Market Size by Country
6.3.1 North America Anti-depressant Drugs Sales by Country (2017-2028)
6.3.2 North America Anti-depressant Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-depressant Drugs Market Size by Type
7.1.1 Europe Anti-depressant Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti-depressant Drugs Revenue by Type (2017-2028)
7.2 Europe Anti-depressant Drugs Market Size by Application
7.2.1 Europe Anti-depressant Drugs Sales by Application (2017-2028)
7.2.2 Europe Anti-depressant Drugs Revenue by Application (2017-2028)
7.3 Europe Anti-depressant Drugs Market Size by Country
7.3.1 Europe Anti-depressant Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti-depressant Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-depressant Drugs Market Size by Type
8.1.1 Asia Pacific Anti-depressant Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-depressant Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-depressant Drugs Market Size by Application
8.2.1 Asia Pacific Anti-depressant Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-depressant Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-depressant Drugs Market Size by Region
8.3.1 Asia Pacific Anti-depressant Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-depressant Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-depressant Drugs Market Size by Type
9.1.1 Latin America Anti-depressant Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti-depressant Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti-depressant Drugs Market Size by Application
9.2.1 Latin America Anti-depressant Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anti-depressant Drugs Revenue by Application (2017-2028)
9.3 Latin America Anti-depressant Drugs Market Size by Country
9.3.1 Latin America Anti-depressant Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti-depressant Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-depressant Drugs Market Size by Type
10.1.1 Middle East and Africa Anti-depressant Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-depressant Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-depressant Drugs Market Size by Application
10.2.1 Middle East and Africa Anti-depressant Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-depressant Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-depressant Drugs Market Size by Country
10.3.1 Middle East and Africa Anti-depressant Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-depressant Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Corporation Information
11.1.2 Alkermes Overview
11.1.3 Alkermes Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Alkermes Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkermes Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Lundbeck
11.6.1 Lundbeck Corporation Information
11.6.2 Lundbeck Overview
11.6.3 Lundbeck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lundbeck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lundbeck Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Corporation Information
11.9.2 Teva Pharmaceutical Industries Overview
11.9.3 Teva Pharmaceutical Industries Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teva Pharmaceutical Industries Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Corporation Information
11.10.2 Takeda Pharmaceutical Company Overview
11.10.3 Takeda Pharmaceutical Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Pharmaceutical Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Pharmaceutical Company Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Corporation Information
11.11.2 AstraZeneca Overview
11.11.3 AstraZeneca Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 AstraZeneca Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Recent Developments
11.12 Johnson and Johnson
11.12.1 Johnson and Johnson Corporation Information
11.12.2 Johnson and Johnson Overview
11.12.3 Johnson and Johnson Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Johnson and Johnson Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Johnson and Johnson Recent Developments
11.13 Sanofi
11.13.1 Sanofi Corporation Information
11.13.2 Sanofi Overview
11.13.3 Sanofi Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sanofi Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sanofi Recent Developments
11.14 Sun Pharmaceuticals
11.14.1 Sun Pharmaceuticals Corporation Information
11.14.2 Sun Pharmaceuticals Overview
11.14.3 Sun Pharmaceuticals Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sun Pharmaceuticals Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sun Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-depressant Drugs Industry Chain Analysis
12.2 Anti-depressant Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-depressant Drugs Production Mode & Process
12.4 Anti-depressant Drugs Sales and Marketing
12.4.1 Anti-depressant Drugs Sales Channels
12.4.2 Anti-depressant Drugs Distributors
12.5 Anti-depressant Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-depressant Drugs Industry Trends
13.2 Anti-depressant Drugs Market Drivers
13.3 Anti-depressant Drugs Market Challenges
13.4 Anti-depressant Drugs Market Restraints
14 Key Findings in The Global Anti-depressant Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Anti-depressant Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Selective Serotonin Reuptake Inhibitor (SSRI)
    Table 3. Major Manufacturers of Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
    Table 4. Major Manufacturers of Tricyclic Antidepressant (TCA)
    Table 5. Major Manufacturers of Monoamine Oxidase Inhibitor (MAOI)
    Table 6. Major Manufacturers of Others
    Table 7. Global Anti-depressant Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Anti-depressant Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Anti-depressant Drugs Sales by Region (2017-2022) & (K Units)
    Table 10. Global Anti-depressant Drugs Sales Market Share by Region (2017-2022)
    Table 11. Global Anti-depressant Drugs Sales by Region (2023-2028) & (K Units)
    Table 12. Global Anti-depressant Drugs Sales Market Share by Region (2023-2028)
    Table 13. Global Anti-depressant Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Anti-depressant Drugs Revenue Market Share by Region (2017-2022)
    Table 15. Global Anti-depressant Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Anti-depressant Drugs Revenue Market Share by Region (2023-2028)
    Table 17. Global Anti-depressant Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Anti-depressant Drugs Sales Share by Manufacturers (2017-2022)
    Table 19. Global Anti-depressant Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Anti-depressant Drugs Revenue Share by Manufacturers (2017-2022)
    Table 21. Anti-depressant Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Anti-depressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Anti-depressant Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-depressant Drugs as of 2021)
    Table 24. Anti-depressant Drugs Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Anti-depressant Drugs Product Offered
    Table 26. Date of Manufacturers Enter into Anti-depressant Drugs Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Anti-depressant Drugs Sales by Type (2017-2022) & (K Units)
    Table 29. Global Anti-depressant Drugs Sales by Type (2023-2028) & (K Units)
    Table 30. Global Anti-depressant Drugs Sales Share by Type (2017-2022)
    Table 31. Global Anti-depressant Drugs Sales Share by Type (2023-2028)
    Table 32. Global Anti-depressant Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Anti-depressant Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Anti-depressant Drugs Revenue Share by Type (2017-2022)
    Table 35. Global Anti-depressant Drugs Revenue Share by Type (2023-2028)
    Table 36. Anti-depressant Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Anti-depressant Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Anti-depressant Drugs Sales by Application (2017-2022) & (K Units)
    Table 39. Global Anti-depressant Drugs Sales by Application (2023-2028) & (K Units)
    Table 40. Global Anti-depressant Drugs Sales Share by Application (2017-2022)
    Table 41. Global Anti-depressant Drugs Sales Share by Application (2023-2028)
    Table 42. Global Anti-depressant Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Anti-depressant Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Anti-depressant Drugs Revenue Share by Application (2017-2022)
    Table 45. Global Anti-depressant Drugs Revenue Share by Application (2023-2028)
    Table 46. Anti-depressant Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Anti-depressant Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Anti-depressant Drugs Sales by Type (2017-2022) & (K Units)
    Table 49. North America Anti-depressant Drugs Sales by Type (2023-2028) & (K Units)
    Table 50. North America Anti-depressant Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Anti-depressant Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Anti-depressant Drugs Sales by Application (2017-2022) & (K Units)
    Table 53. North America Anti-depressant Drugs Sales by Application (2023-2028) & (K Units)
    Table 54. North America Anti-depressant Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Anti-depressant Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Anti-depressant Drugs Sales by Country (2017-2022) & (K Units)
    Table 57. North America Anti-depressant Drugs Sales by Country (2023-2028) & (K Units)
    Table 58. North America Anti-depressant Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Anti-depressant Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Anti-depressant Drugs Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Anti-depressant Drugs Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Anti-depressant Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Anti-depressant Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Anti-depressant Drugs Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Anti-depressant Drugs Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Anti-depressant Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Anti-depressant Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Anti-depressant Drugs Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Anti-depressant Drugs Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Anti-depressant Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Anti-depressant Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Anti-depressant Drugs Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Anti-depressant Drugs Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Anti-depressant Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Anti-depressant Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Anti-depressant Drugs Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Anti-depressant Drugs Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Anti-depressant Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Anti-depressant Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Anti-depressant Drugs Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Anti-depressant Drugs Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Anti-depressant Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Anti-depressant Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Anti-depressant Drugs Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Anti-depressant Drugs Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Anti-depressant Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Anti-depressant Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Anti-depressant Drugs Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Anti-depressant Drugs Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Anti-depressant Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Anti-depressant Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Anti-depressant Drugs Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Anti-depressant Drugs Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Anti-depressant Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Anti-depressant Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Anti-depressant Drugs Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Anti-depressant Drugs Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Anti-depressant Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Anti-depressant Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Anti-depressant Drugs Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Anti-depressant Drugs Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Anti-depressant Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Anti-depressant Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Anti-depressant Drugs Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Anti-depressant Drugs Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Anti-depressant Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Anti-depressant Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Alkermes Corporation Information
    Table 109. Alkermes Description and Major Businesses
    Table 110. Alkermes Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Alkermes Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Alkermes Recent Developments
    Table 113. Allergan Corporation Information
    Table 114. Allergan Description and Major Businesses
    Table 115. Allergan Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Allergan Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Allergan Recent Developments
    Table 118. Bristol-Myers Squibb Corporation Information
    Table 119. Bristol-Myers Squibb Description and Major Businesses
    Table 120. Bristol-Myers Squibb Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Bristol-Myers Squibb Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Bristol-Myers Squibb Recent Developments
    Table 123. Eli Lilly and Company Corporation Information
    Table 124. Eli Lilly and Company Description and Major Businesses
    Table 125. Eli Lilly and Company Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Eli Lilly and Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Eli Lilly and Company Recent Developments
    Table 128. GlaxoSmithKline Corporation Information
    Table 129. GlaxoSmithKline Description and Major Businesses
    Table 130. GlaxoSmithKline Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. GlaxoSmithKline Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. GlaxoSmithKline Recent Developments
    Table 133. Lundbeck Corporation Information
    Table 134. Lundbeck Description and Major Businesses
    Table 135. Lundbeck Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Lundbeck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Lundbeck Recent Developments
    Table 138. Merck Corporation Information
    Table 139. Merck Description and Major Businesses
    Table 140. Merck Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Merck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Merck Recent Developments
    Table 143. Pfizer Corporation Information
    Table 144. Pfizer Description and Major Businesses
    Table 145. Pfizer Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Pfizer Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Pfizer Recent Developments
    Table 148. Teva Pharmaceutical Industries Corporation Information
    Table 149. Teva Pharmaceutical Industries Description and Major Businesses
    Table 150. Teva Pharmaceutical Industries Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Teva Pharmaceutical Industries Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Teva Pharmaceutical Industries Recent Developments
    Table 153. Takeda Pharmaceutical Company Corporation Information
    Table 154. Takeda Pharmaceutical Company Description and Major Businesses
    Table 155. Takeda Pharmaceutical Company Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Takeda Pharmaceutical Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Takeda Pharmaceutical Company Recent Developments
    Table 158. AstraZeneca Corporation Information
    Table 159. AstraZeneca Description and Major Businesses
    Table 160. AstraZeneca Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. AstraZeneca Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. AstraZeneca Recent Developments
    Table 163. Johnson and Johnson Corporation Information
    Table 164. Johnson and Johnson Description and Major Businesses
    Table 165. Johnson and Johnson Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 166. Johnson and Johnson Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Johnson and Johnson Recent Developments
    Table 168. Sanofi Corporation Information
    Table 169. Sanofi Description and Major Businesses
    Table 170. Sanofi Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 171. Sanofi Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Sanofi Recent Developments
    Table 173. Sun Pharmaceuticals Corporation Information
    Table 174. Sun Pharmaceuticals Description and Major Businesses
    Table 175. Sun Pharmaceuticals Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 176. Sun Pharmaceuticals Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Sun Pharmaceuticals Recent Developments
    Table 178. Key Raw Materials Lists
    Table 179. Raw Materials Key Suppliers Lists
    Table 180. Anti-depressant Drugs Distributors List
    Table 181. Anti-depressant Drugs Customers List
    Table 182. Anti-depressant Drugs Market Trends
    Table 183. Anti-depressant Drugs Market Drivers
    Table 184. Anti-depressant Drugs Market Challenges
    Table 185. Anti-depressant Drugs Market Restraints
    Table 186. Research Programs/Design for This Report
    Table 187. Key Data Information from Secondary Sources
    Table 188. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-depressant Drugs Product Picture
    Figure 3. Global Anti-depressant Drugs Market Share by Type in 2021 & 2028
    Figure 3. Selective Serotonin Reuptake Inhibitor (SSRI) Product Picture
    Figure 4. Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Product Picture
    Figure 5. Tricyclic Antidepressant (TCA) Product Picture
    Figure 6. Monoamine Oxidase Inhibitor (MAOI) Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Anti-depressant Drugs Market Share by Application in 2021 & 2028
    Figure 9. Major Depressive Disorder
    Figure 10. Obsessive-Compulsive Disorder
    Figure 11. Generalized Anxiety Disorder
    Figure 12. Panic Disorder
    Figure 13. Others
    Figure 14. Anti-depressant Drugs Report Years Considered
    Figure 15. Global Anti-depressant Drugs Sales 2017-2028 (K Units)
    Figure 16. Global Anti-depressant Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Anti-depressant Drugs Revenue 2017-2028 (US$ Million)
    Figure 18. Global Anti-depressant Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Anti-depressant Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Anti-depressant Drugs Sales Market Share by Region (2023-2028)
    Figure 21. North America Anti-depressant Drugs Sales YoY (2017-2028) & (K Units)
    Figure 22. North America Anti-depressant Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Anti-depressant Drugs Sales YoY (2017-2028) & (K Units)
    Figure 24. Europe Anti-depressant Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Anti-depressant Drugs Sales YoY (2017-2028) & (K Units)
    Figure 26. Asia-Pacific Anti-depressant Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Anti-depressant Drugs Sales YoY (2017-2028) & (K Units)
    Figure 28. Latin America Anti-depressant Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Anti-depressant Drugs Sales YoY (2017-2028) & (K Units)
    Figure 30. Middle East & Africa Anti-depressant Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Anti-depressant Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Anti-depressant Drugs in the World: Market Share by Anti-depressant Drugs Revenue in 2021
    Figure 33. Global Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Anti-depressant Drugs Sales Market Share by Type (2017-2028)
    Figure 35. Global Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
    Figure 36. Global Anti-depressant Drugs Sales Market Share by Application (2017-2028)
    Figure 37. Global Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
    Figure 38. North America Anti-depressant Drugs Sales Market Share by Type (2017-2028)
    Figure 39. North America Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
    Figure 40. North America Anti-depressant Drugs Sales Market Share by Application (2017-2028)
    Figure 41. North America Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
    Figure 42. North America Anti-depressant Drugs Sales Share by Country (2017-2028)
    Figure 43. North America Anti-depressant Drugs Revenue Share by Country (2017-2028)
    Figure 44. U.S. Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Anti-depressant Drugs Sales Market Share by Type (2017-2028)
    Figure 47. Europe Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Anti-depressant Drugs Sales Market Share by Application (2017-2028)
    Figure 49. Europe Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Anti-depressant Drugs Sales Share by Country (2017-2028)
    Figure 51. Europe Anti-depressant Drugs Revenue Share by Country (2017-2028)
    Figure 52. Germany Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. France Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Anti-depressant Drugs Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Anti-depressant Drugs Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Anti-depressant Drugs Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Anti-depressant Drugs Revenue Share by Region (2017-2028)
    Figure 63. China Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. India Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Anti-depressant Drugs Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Anti-depressant Drugs Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Anti-depressant Drugs Sales Share by Country (2017-2028)
    Figure 78. Latin America Anti-depressant Drugs Revenue Share by Country (2017-2028)
    Figure 79. Mexico Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Anti-depressant Drugs Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Anti-depressant Drugs Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Anti-depressant Drugs Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Anti-depressant Drugs Revenue Share by Country (2017-2028)
    Figure 88. Turkey Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Anti-depressant Drugs Revenue (2017-2028) & (US$ Million)
    Figure 91. Anti-depressant Drugs Value Chain
    Figure 92. Anti-depressant Drugs Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global Nebivolol Hydrochloride Market Insights Forecast to 2028
Global Nebivolol Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-12T7632
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nefopam Hydrochloride Market Insights Forecast to 2028
Global Nefopam Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-36U7490
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Naratriptan Hydrochloride Market Insights Forecast to 2028
Global Naratriptan Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-14C7602
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart